253 related articles for article (PubMed ID: 23759937)
1. Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry.
Dabbs DJ; Schnitt SJ; Geyer FC; Weigelt B; Baehner FL; Decker T; Eusebi V; Fox SB; Ichihara S; Lakhani SR; Palacios J; Rakha E; Richardson AL; Schmitt FC; Tan PH; Tse GM; Vincent-Salomon A; Ellis IO; Badve S; Reis-Filho JS
Am J Surg Pathol; 2013 Jul; 37(7):e1-11. PubMed ID: 23759937
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.
De Leeuw WJ; Berx G; Vos CB; Peterse JL; Van de Vijver MJ; Litvinov S; Van Roy F; Cornelisse CJ; Cleton-Jansen AM
J Pathol; 1997 Dec; 183(4):404-11. PubMed ID: 9496256
[TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of E-cadherin in lobular carcinomas of the breast.
Da Silva L; Parry S; Reid L; Keith P; Waddell N; Kossai M; Clarke C; Lakhani SR; Simpson PT
Am J Surg Pathol; 2008 May; 32(5):773-83. PubMed ID: 18379416
[TBL] [Abstract][Full Text] [Related]
4. E-cadherin alterations in atypical lobular hyperplasia and lobular carcinoma in situ of the breast.
Mastracci TL; Tjan S; Bane AL; O'Malley FP; Andrulis IL
Mod Pathol; 2005 Jun; 18(6):741-51. PubMed ID: 15696125
[TBL] [Abstract][Full Text] [Related]
5. Pleomorphic lobular carcinoma of the breast: role of comprehensive molecular pathology in characterization of an entity.
Reis-Filho JS; Simpson PT; Jones C; Steele D; Mackay A; Iravani M; Fenwick K; Valgeirsson H; Lambros M; Ashworth A; Palacios J; Schmitt F; Lakhani SR
J Pathol; 2005 Sep; 207(1):1-13. PubMed ID: 15957152
[TBL] [Abstract][Full Text] [Related]
6. Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry.
Wells JM; Pipa J; Shin SJ
Am J Surg Pathol; 2014 Mar; 38(3):434-5. PubMed ID: 24441664
[No Abstract] [Full Text] [Related]
7. Lobular versus ductal breast neoplasms: the diagnostic utility of p120 catenin.
Dabbs DJ; Bhargava R; Chivukula M
Am J Surg Pathol; 2007 Mar; 31(3):427-37. PubMed ID: 17325485
[TBL] [Abstract][Full Text] [Related]
8. E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis.
Vos CB; Cleton-Jansen AM; Berx G; de Leeuw WJ; ter Haar NT; van Roy F; Cornelisse CJ; Peterse JL; van de Vijver MJ
Br J Cancer; 1997; 76(9):1131-3. PubMed ID: 9365159
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications.
Acs G; Lawton TJ; Rebbeck TR; LiVolsi VA; Zhang PJ
Am J Clin Pathol; 2001 Jan; 115(1):85-98. PubMed ID: 11190811
[TBL] [Abstract][Full Text] [Related]
10. Cadherin-catenin complex dissociation in lobular neoplasia of the breast.
Morrogh M; Andrade VP; Giri D; Sakr RA; Paik W; Qin LX; Arroyo CD; Brogi E; Morrow M; King TA
Breast Cancer Res Treat; 2012 Apr; 132(2):641-52. PubMed ID: 22080244
[TBL] [Abstract][Full Text] [Related]
11. Lobular neoplasia.
King TA; Reis-Filho JS
Surg Oncol Clin N Am; 2014 Jul; 23(3):487-503. PubMed ID: 24882347
[TBL] [Abstract][Full Text] [Related]
12. Lobular neoplasia of the breast: an update.
Contreras A; Sattar H
Arch Pathol Lab Med; 2009 Jul; 133(7):1116-20. PubMed ID: 19642738
[TBL] [Abstract][Full Text] [Related]
13. Frequent E-cadherin gene inactivation by loss of heterozygosity in pleomorphic lobular carcinoma of the breast.
Palacios J; Sarrió D; García-Macias MC; Bryant B; Sobel ME; Merino MJ
Mod Pathol; 2003 Jul; 16(7):674-8. PubMed ID: 12861063
[TBL] [Abstract][Full Text] [Related]
14. Cytokeratin 8 immunostaining pattern and E-cadherin expression distinguish lobular from ductal breast carcinoma.
Lehr HA; Folpe A; Yaziji H; Kommoss F; Gown AM
Am J Clin Pathol; 2000 Aug; 114(2):190-6. PubMed ID: 10941333
[TBL] [Abstract][Full Text] [Related]
15. Mixed pleomorphic lobular and apocrine carcinoma of the breast: A case report suggesting pathogenesis.
Ishii A; Oishi T; Kakuda Y; Yasui H; Kawata T; Muramatsu K; Takahashi K; Sugino T
Pathol Int; 2019 May; 69(5):288-293. PubMed ID: 30811750
[TBL] [Abstract][Full Text] [Related]
16. Interobserver variability and aberrant E-cadherin immunostaining of lobular neoplasia and infiltrating lobular carcinoma.
Choi YJ; Pinto MM; Hao L; Riba AK
Mod Pathol; 2008 Oct; 21(10):1224-37. PubMed ID: 18587329
[TBL] [Abstract][Full Text] [Related]
17. The ductal phenotypic expression of the E-cadherin/catenin complex in tubulolobular carcinoma of the breast: an immunohistochemical and clinicopathologic study.
Esposito NN; Chivukula M; Dabbs DJ
Mod Pathol; 2007 Jan; 20(1):130-8. PubMed ID: 17143261
[TBL] [Abstract][Full Text] [Related]
18. [Expression of E-cadherin, p120catenin and 34βE12 in invasive lobular carcinoma of breast and their roles in diagnosis].
Yang GZ; Zhang XL; Li J; Ding HY
Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):741-4. PubMed ID: 22336156
[TBL] [Abstract][Full Text] [Related]
19. [Expression of E-cadherine as a differential diagnostic fest for lobular infiltrative breast cancers].
Chipysheva TA; Ermilova VD; Vishnevskaia IaV; Vasil'ev IuM
Arkh Patol; 2005; 67(6):24-7. PubMed ID: 16405017
[TBL] [Abstract][Full Text] [Related]
20. E-cadherin expression in pleomorphic lobular carcinoma: an aid to differentiation from ductal carcinoma.
Wahed A; Connelly J; Reese T
Ann Diagn Pathol; 2002 Dec; 6(6):349-51. PubMed ID: 12478484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
